Rituximab as successful adjunct treatment in a patient with disseminated nontuberculous mycobacterial infection due to acquired anti-interferon- autoantibody

Clinical Infectious Diseases

Volumn 58, Issue 6, 2014, Pages

  Czaja, Christopher A ^a   Merkel, Patricia A ^b   Chan, Edward D ^a   Lenz, Laurel L ^c   Wolf, Molly L ^d   Alam, Rafeul ^e   Frankel, Stephen K ^f   Fischer, Aryeh ^g   Gogate, Shaila ^h   Perez Velez, Carlos M ⁱ   Knight, Vijaya ^b,d  

^a Division of Mycobacterial and Respiratory Infections   (United States)

^b Departments of Pathology   (United States)

^c Integrated Department of Immunology   (United States)

^d Kaiser Permanente   (United States)

^e Division of Allergy Clinical Immunology   (United States)

^f Division of Pulmonary Sciences and Critical Care Medicine   (United States)

^g DEPARTMENT OF MEDICINE   (United States)

^h Allergy Asthma Colorado PC   (United States)

ⁱ UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

immune deficiency; interferon gamma; nontuberculous mycobacteria; rituximab

Indexed keywords

ACQUIRED INTERFERON GAMMA AUTOANTIBODY; ANTIMYCOBACTERIAL AGENT; AUTOANTIBODY; AZITHROMYCIN; CILASTATIN PLUS IMIPENEM; CLOFAZIMINE; GAMMA INTERFERON ANTIBODY; IMIPENEM; INTERLEUKIN 12; METHYLPREDNISOLONE; MOXIFLOXACIN; PREDNISONE; RITUXIMAB; TOBRAMYCIN; UNCLASSIFIED DRUG; GAMMA INTERFERON; IMMUNOLOGIC FACTOR; MONOCLONAL ANTIBODY;

ABSCESS; ADJUVANT THERAPY; AGED; ANTIBIOTIC THERAPY; ARTHRALGIA; ARTICLE; AXILLARY LYMPHADENOPATHY; BONE MARROW EDEMA; CASE REPORT; CERVICAL LYMPHADENOPATHY; COUGHING; CYTOMEGALOVIRUS; DISEASE EXACERBATION; DISKITIS; DISSEMINATED NONTUBERCULOUS MYCOBACTERIAL INFECTION; DRUG DOSE TITRATION; EPSTEIN BARR VIRUS; ERYTHROCYTE SEDIMENTATION RATE; GRANULOMA; GRANULOMATOSIS; HAND RASH; HERPES ZOSTER; HUMAN; HYPERPLASIA; IMMUNOTHERAPY; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; INTRATHORACIC LYMPHADENOPATHY; LEUKOCYTOCLASTIC VASCULITIS; LUNG FIBROSIS; LYMPHADENITIS; LYMPHADENOPATHY; LYMPHOCYTE PROLIFERATION; MALE; MEDICAL HISTORY; MULTIDERMATOMAL ZOSTER; MYCOBACTERIOSIS; MYCOBACTERIUM ABSCESSUS; NECK PAIN; OSTEOMYELITIS; OUTCOME ASSESSMENT; PLASMACYTOSIS; PRIORITY JOURNAL; RECURRENT DISEASE; TREATMENT DURATION; BLOOD; IMMUNOLOGY; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS;

AGED; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; AUTOANTIBODIES; HUMANS; IMMUNOLOGIC FACTORS; INTERFERON-GAMMA; MALE; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS;

EID: 84895767855     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit809     Document Type: Article

References (12)

1. Browne SK, Burbelo PD, Chetchotisakd P, et al. Adult-onset immunodeficiency in Thailand and Taiwan. New Engl J Med 2012; 367:725-34.
2. Browne SK, Zaman R, Sampaio EP, et al. Anti-CD20 (rituximab) therapy for anti-IFN-gamma autoantibody-associated nontuberculous mycobacterial infection. Blood 2012; 119:3933-9.
3. Patel SY, Ding L, Brown MR, et al. Anti-IFN-gamma autoantibodies in disseminated nontuberculous mycobacterial infections. J Immunol 2005; 175:4769-76.
4. Chetchotisakd P, Mootsikapun P, Anunnatsiri S, et al. Disseminated infection due to rapidly growing mycobacteria in immunocompetent hosts presenting with chronic lymphadenopathy: a previously unrecognized clinical entity. Clin Infect Dis 2000; 30:29-34.
5. Chetchotisakd P, Kiertiburanakul S, Mootsikapun P, Assanasen S, Chaiwarith R, Anunnatsiri S. Disseminated nontuberculous mycobacterial infection in patients who are not infected with HIV in Thailand. Clin Infect Dis 2007; 45:421-7.
6. Doffinger R, Helbert MR, Barcenas-Morales G, et al. Autoantibodies to interferon-gamma in a patient with selective susceptibility to mycobacterial infection and organ-specific autoimmunity. Clin Infect Dis 2004; 38:e10-4.
7. Hoflich C, Sabat R, Rosseau S, et al. Naturally occurring anti-IFNgamma autoantibody and severe infections with Mycobacterium cheloneae and Burkholderia cocovenenans. Blood 2004; 103:673-5.
8. Kampitak T, Suwanpimolkul G, Browne S, Suankratay C. Anti-interferon- gamma autoantibody and opportunistic infections: case series and review of the literature. Infection 2011; 39:65-71.
9. Kampmann B, Hemingway C, Stephens A, et al. Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-gamma. J Clin Invest 2005; 115:2480-8.
10. Koya T, Tsubata C, Kagamu H, et al. Anti-interferon-gamma autoantibody in a patient with disseminated Mycobacterium avium complex. J Infect Chemother 2009; 15:118-22.
11. Poulin S, Corbeil C, Nguyen M, et al. Fatal Mycobacterium colombiense/ cytomegalovirus coinfection associated with acquired immunodeficiency due to autoantibodies against interferon gamma: a case report. BMC Infect Dis 2013; 13:24.
12. Chi CY, Chu CC, Liu JP, et al. Anti-IFN-gamma autoantibodies in adults with disseminated nontuberculous mycobacterial infections are associated with HLA-DRB116:02 and HLA-DQB105:02 and the reactivation of latent varicella-zoster virus infection. Blood 2013; 121: 1357-66.